Prestige Consumer Healthcare Inc. $PBH Shares Sold by Amica Mutual Insurance Co.

Amica Mutual Insurance Co. cut its stake in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) by 34.7% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 8,167 shares of the company’s stock after selling 4,334 shares during the period. Amica Mutual Insurance Co.’s holdings in Prestige Consumer Healthcare were worth $652,000 at the end of the most recent quarter.

Other hedge funds have also modified their holdings of the company. UMB Bank n.a. increased its stake in Prestige Consumer Healthcare by 81.8% in the 2nd quarter. UMB Bank n.a. now owns 320 shares of the company’s stock worth $26,000 after purchasing an additional 144 shares in the last quarter. Caitong International Asset Management Co. Ltd boosted its holdings in shares of Prestige Consumer Healthcare by 312.5% in the second quarter. Caitong International Asset Management Co. Ltd now owns 330 shares of the company’s stock worth $26,000 after buying an additional 250 shares during the period. Maseco LLP acquired a new position in shares of Prestige Consumer Healthcare in the second quarter worth about $27,000. First Horizon Advisors Inc. increased its position in shares of Prestige Consumer Healthcare by 294.1% in the second quarter. First Horizon Advisors Inc. now owns 599 shares of the company’s stock worth $48,000 after acquiring an additional 447 shares in the last quarter. Finally, Geneos Wealth Management Inc. raised its holdings in shares of Prestige Consumer Healthcare by 92.8% during the first quarter. Geneos Wealth Management Inc. now owns 559 shares of the company’s stock valued at $48,000 after acquiring an additional 269 shares during the period. 99.95% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on PBH shares. Wall Street Zen lowered shares of Prestige Consumer Healthcare from a “buy” rating to a “hold” rating in a research note on Saturday, August 9th. Canaccord Genuity Group reduced their target price on Prestige Consumer Healthcare from $100.00 to $88.00 and set a “buy” rating for the company in a report on Friday. Jefferies Financial Group decreased their target price on Prestige Consumer Healthcare from $75.00 to $71.00 and set a “hold” rating for the company in a research report on Monday, October 27th. Zacks Research lowered Prestige Consumer Healthcare from a “hold” rating to a “strong sell” rating in a research report on Thursday, September 4th. Finally, Sidoti raised Prestige Consumer Healthcare from a “neutral” rating to a “buy” rating and set a $80.00 price objective for the company in a research note on Wednesday, September 24th. Four analysts have rated the stock with a Buy rating, three have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the company has a consensus rating of “Hold” and an average target price of $85.33.

Prestige Consumer Healthcare Stock Down 2.5%

PBH opened at $59.85 on Friday. The company has a market capitalization of $2.95 billion, a PE ratio of 14.05, a price-to-earnings-growth ratio of 1.93 and a beta of 0.41. The company has a debt-to-equity ratio of 0.55, a current ratio of 4.38 and a quick ratio of 2.99. Prestige Consumer Healthcare Inc. has a fifty-two week low of $59.51 and a fifty-two week high of $90.04. The business has a 50-day moving average of $62.98 and a 200-day moving average of $73.18.

Prestige Consumer Healthcare (NYSE:PBH) last released its quarterly earnings data on Thursday, November 6th. The company reported $1.07 EPS for the quarter, topping analysts’ consensus estimates of $0.97 by $0.10. The firm had revenue of $274.11 million for the quarter, compared to the consensus estimate of $257.14 million. Prestige Consumer Healthcare had a return on equity of 12.69% and a net margin of 19.02%.The firm’s revenue was down 3.4% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.09 earnings per share. Prestige Consumer Healthcare has set its FY 2026 guidance at 4.540-4.580 EPS. Equities research analysts forecast that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current fiscal year.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.